Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-011923
Filing Date
2022-08-03
Accepted
2022-08-03 16:54:08
Documents
63
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xncr-20220630x10q.htm   iXBRL 10-Q 1994276
2 EX-10.1 xncr-20220630xex10d1.htm EX-10.1 72533
3 EX-31.1 xncr-20220630xex31d1.htm EX-31.1 17009
4 EX-31.2 xncr-20220630xex31d2.htm EX-31.2 16943
5 EX-32.1 xncr-20220630xex32d1.htm EX-32.1 10018
  Complete submission text file 0001558370-22-011923.txt   8325553

Data Files

Seq Description Document Type Size
6 EX-101.SCH xncr-20220630.xsd EX-101.SCH 42951
7 EX-101.CAL xncr-20220630_cal.xml EX-101.CAL 53817
8 EX-101.DEF xncr-20220630_def.xml EX-101.DEF 207626
9 EX-101.LAB xncr-20220630_lab.xml EX-101.LAB 435868
10 EX-101.PRE xncr-20220630_pre.xml EX-101.PRE 337938
57 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20220630x10q_htm.xml XML 1752827
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36182 | Film No.: 221133412
SIC: 2834 Pharmaceutical Preparations